BR0211198A - Composições farmacêuticas e seu uso - Google Patents
Composições farmacêuticas e seu usoInfo
- Publication number
- BR0211198A BR0211198A BR0211198-5A BR0211198A BR0211198A BR 0211198 A BR0211198 A BR 0211198A BR 0211198 A BR0211198 A BR 0211198A BR 0211198 A BR0211198 A BR 0211198A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- tablets
- terbinafine
- mini
- pellets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Abstract
"COMPOSIçõES FARMACêUTICAS E SEU USO". A presente invenção refere-se a composições farmacêuticas para administração oral, compreendendo terbinafina, e um método para administrar altas doses, e ao mesmo tempo minimizar os efeitos associados a, por exemplo, altas cargas de dosagem, como, por exemplo, formulações multiparticuladas ou em comprimidos revestidos, tais como minicomprimidos ou péletes, por exemplo, em cápsulas.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0117760A GB0117760D0 (en) | 2001-07-20 | 2001-07-20 | Organic compounds |
GB0128993A GB0128993D0 (en) | 2001-12-04 | 2001-12-04 | Organic compounds |
GB0212209A GB0212209D0 (en) | 2002-05-27 | 2002-05-27 | Organic compounds |
PCT/EP2002/008095 WO2003022267A1 (en) | 2001-07-20 | 2002-07-19 | Pharmaceutical compositions containing terbinafin and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211198A true BR0211198A (pt) | 2004-08-10 |
Family
ID=27256227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211198-5A BR0211198A (pt) | 2001-07-20 | 2002-07-19 | Composições farmacêuticas e seu uso |
Country Status (28)
Country | Link |
---|---|
US (2) | US20040198838A1 (pt) |
EP (1) | EP1411921B2 (pt) |
JP (3) | JP2005503399A (pt) |
KR (2) | KR100651110B1 (pt) |
CN (1) | CN100358518C (pt) |
AR (1) | AR034813A1 (pt) |
AT (1) | ATE381329T1 (pt) |
AU (1) | AU2002321249B2 (pt) |
BR (1) | BR0211198A (pt) |
CA (1) | CA2453263C (pt) |
CY (1) | CY1107861T1 (pt) |
DE (1) | DE60224194T3 (pt) |
DK (1) | DK1411921T4 (pt) |
ES (1) | ES2295381T5 (pt) |
HK (1) | HK1067299A1 (pt) |
HU (1) | HUP0401200A3 (pt) |
IL (2) | IL159591A0 (pt) |
MX (1) | MXPA04000627A (pt) |
MY (1) | MY136136A (pt) |
NO (1) | NO332268B1 (pt) |
NZ (1) | NZ530648A (pt) |
PE (1) | PE20030287A1 (pt) |
PL (1) | PL365416A1 (pt) |
PT (1) | PT1411921E (pt) |
RU (1) | RU2298402C2 (pt) |
SI (1) | SI1411921T2 (pt) |
TW (1) | TWI302460B (pt) |
WO (1) | WO2003022267A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
JP2005538067A (ja) * | 2002-07-02 | 2005-12-15 | ノバルティス アクチエンゲゼルシャフト | 副鼻腔炎の処置方法 |
JP2005060310A (ja) * | 2003-08-13 | 2005-03-10 | Towa Yakuhin Kk | 不快な味をマスキングする経口投与用製剤 |
JP2005187339A (ja) * | 2003-12-24 | 2005-07-14 | Iwaki Seiyaku Co Ltd | 耐光性塩酸テルビナフィンフィルムコート錠 |
JP4999297B2 (ja) * | 2005-08-10 | 2012-08-15 | 高田製薬株式会社 | 高含量塩酸テルビナフィン小型錠剤 |
US8815285B2 (en) * | 2006-03-28 | 2014-08-26 | Wockhardt Ltd. | Extended release dosage forms of metoprolol |
CN1820744B (zh) * | 2006-04-04 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 磷酸奥司他韦颗粒剂及其制备方法 |
HUE029173T2 (hu) * | 2006-04-26 | 2017-02-28 | Alphapharm Pty Ltd | Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot |
CA2649372A1 (en) * | 2006-06-07 | 2007-12-13 | Novartis Ag | Process for making multiparticulates using a roller compactor |
PT2391345E (pt) * | 2009-01-28 | 2014-12-03 | Novartis Ag | Formulações galénicas compreendendo aliscireno |
WO2010086732A1 (en) * | 2009-01-30 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd | Stable compositions for nail and skin treatment |
CN102198111A (zh) * | 2011-06-17 | 2011-09-28 | 哈尔滨乐泰药业有限公司 | 一种抗真菌药物片剂的制备方法 |
WO2013043143A1 (ru) * | 2011-09-21 | 2013-03-28 | Slyusar Viktor Timopheevich | Способ снижения лишнего веса |
CA2866276A1 (en) * | 2012-03-07 | 2013-09-12 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
BR112018068665B1 (pt) | 2016-03-15 | 2023-12-26 | Acer Therapeutics Inc | Composição farmacêutica de fenilbutirato de sódio, método de produção da mesma e seus usos |
US11504687B2 (en) | 2016-10-11 | 2022-11-22 | Khalifa University of Science and Technology | Coated chloride salt particles and methods of making and using the same |
CN109833301A (zh) * | 2017-11-29 | 2019-06-04 | 天津市保灵动物保健品有限公司 | 一种犬猫用盐酸特比萘芬风味片及其制备工艺 |
CN109925296B (zh) * | 2017-12-19 | 2021-09-07 | 四川济生堂药业有限公司 | 一种中药微丸的包衣方法 |
CN112156078A (zh) * | 2020-11-11 | 2021-01-01 | 乐泰药业有限公司 | 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK62184D0 (da) † | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
EP0166315B1 (de) * | 1984-06-19 | 1989-08-23 | BASF Aktiengesellschaft | Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten |
US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
US4894375A (en) * | 1986-09-29 | 1990-01-16 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
DE3937455A1 (de) * | 1989-11-10 | 1991-05-16 | Nordmark Arzneimittel Gmbh | Antacidatabletten |
US5262172A (en) * | 1992-06-19 | 1993-11-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing buffered bile acids |
US5234697A (en) * | 1992-06-22 | 1993-08-10 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
US5415872A (en) * | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
US5578304A (en) * | 1992-06-22 | 1996-11-26 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
US5332727A (en) * | 1993-04-29 | 1994-07-26 | Birkmayer U.S.A. | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
AU1313695A (en) * | 1993-12-14 | 1995-07-03 | Sandoz Ltd. | Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates |
FR2722102B1 (fr) * | 1994-07-11 | 1996-08-23 | Cird Galderma | Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses |
GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
NZ280065A (en) * | 1995-09-20 | 1998-04-27 | Apotex Inc | Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives |
CA2184535C (en) * | 1996-08-30 | 2000-04-18 | H. Craig Willis | Apparatus and method for separation of solids from liquid |
DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
FR2755011B1 (fr) * | 1996-10-31 | 1998-11-20 | Cird Galderma | Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v. |
TR199901564T2 (xx) * | 1997-01-06 | 1999-09-21 | Pfizer Inc. | H�zl� ��z�lebilen ve tat-maskesi sa�layan dozaj ispen�iyari formu. |
US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
FR2771291B1 (fr) † | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
DE19842753A1 (de) † | 1998-09-18 | 2000-03-23 | Bayer Ag | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
CA2351720C (en) * | 1998-11-25 | 2006-11-21 | Cima Labs Inc. | Taste masking rapid release coating system |
AU764469B2 (en) † | 1999-01-29 | 2003-08-21 | Disphar International B.V. | Pharmaceutical compositions |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
US6248363B1 (en) † | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
CN1116033C (zh) * | 1999-07-08 | 2003-07-30 | 齐鲁制药厂 | 一种治疗阴道炎的泡腾片剂及其制法 |
JP2003506480A (ja) * | 1999-08-17 | 2003-02-18 | ノバルテイス・コンシユーマー・ヘルス・エス・アー | 急速に溶解する剤形およびその製造方法 |
GB0001315D0 (en) * | 2000-01-20 | 2000-03-08 | Novartis Ag | Organic compounds |
AU2001239838A1 (en) † | 2000-02-24 | 2001-09-03 | Advancis Pharmaceutical Corporation | Therapeutic product, use and formulation thereof |
DE10017996A1 (de) * | 2000-04-11 | 2001-10-18 | Pierre Foss | Lamisil-Intervall-System |
GB0014448D0 (en) * | 2000-06-13 | 2000-08-09 | Novartis Ag | Organic compounds |
AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
WO2004069157A2 (en) * | 2003-01-17 | 2004-08-19 | Ophthalmic Research Associates, Inc. | Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
-
2002
- 2002-07-18 AR ARP020102698A patent/AR034813A1/es unknown
- 2002-07-19 DE DE60224194T patent/DE60224194T3/de not_active Expired - Lifetime
- 2002-07-19 AU AU2002321249A patent/AU2002321249B2/en not_active Ceased
- 2002-07-19 RU RU2004105263/15A patent/RU2298402C2/ru not_active IP Right Cessation
- 2002-07-19 IL IL15959102A patent/IL159591A0/xx unknown
- 2002-07-19 MX MXPA04000627A patent/MXPA04000627A/es active IP Right Grant
- 2002-07-19 DK DK02754918.7T patent/DK1411921T4/da active
- 2002-07-19 CN CNB028141040A patent/CN100358518C/zh not_active Expired - Fee Related
- 2002-07-19 ES ES02754918T patent/ES2295381T5/es not_active Expired - Lifetime
- 2002-07-19 MY MYPI20022738A patent/MY136136A/en unknown
- 2002-07-19 AT AT02754918T patent/ATE381329T1/de active
- 2002-07-19 WO PCT/EP2002/008095 patent/WO2003022267A1/en active IP Right Grant
- 2002-07-19 BR BR0211198-5A patent/BR0211198A/pt not_active IP Right Cessation
- 2002-07-19 SI SI200230669T patent/SI1411921T2/sl unknown
- 2002-07-19 CA CA2453263A patent/CA2453263C/en not_active Expired - Fee Related
- 2002-07-19 KR KR1020047000865A patent/KR100651110B1/ko not_active IP Right Cessation
- 2002-07-19 HU HU0401200A patent/HUP0401200A3/hu unknown
- 2002-07-19 NZ NZ530648A patent/NZ530648A/en not_active IP Right Cessation
- 2002-07-19 KR KR1020067011980A patent/KR100699958B1/ko not_active IP Right Cessation
- 2002-07-19 JP JP2003526396A patent/JP2005503399A/ja not_active Withdrawn
- 2002-07-19 PT PT02754918T patent/PT1411921E/pt unknown
- 2002-07-19 EP EP02754918A patent/EP1411921B2/en not_active Expired - Lifetime
- 2002-07-19 PL PL02365416A patent/PL365416A1/xx not_active Application Discontinuation
- 2002-07-19 US US10/483,436 patent/US20040198838A1/en not_active Abandoned
- 2002-07-19 TW TW091116154A patent/TWI302460B/zh not_active IP Right Cessation
- 2002-07-22 PE PE2002000645A patent/PE20030287A1/es not_active Application Discontinuation
-
2003
- 2003-12-25 IL IL159591A patent/IL159591A/en not_active IP Right Cessation
-
2004
- 2004-01-19 NO NO20040254A patent/NO332268B1/no not_active IP Right Cessation
- 2004-10-18 HK HK04108132A patent/HK1067299A1/xx not_active IP Right Cessation
-
2008
- 2008-01-18 CY CY20081100079T patent/CY1107861T1/el unknown
- 2008-06-17 JP JP2008158153A patent/JP2008280351A/ja active Pending
- 2008-07-18 US US12/218,806 patent/US20080286356A1/en not_active Abandoned
-
2012
- 2012-02-01 JP JP2012020039A patent/JP2012136523A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0211198A (pt) | Composições farmacêuticas e seu uso | |
MX2007006212A (es) | Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular. | |
EP2269613A3 (en) | Solid orald dosage form comprising a combination of metformin and glibenclamide | |
WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
BR0014827A (pt) | Derivados de terc-butil-(7-metil-imidazo (1,2-a) piridin-3-il) amina, procedimento de sua preparação, medicamentos que os contém, sua utilização para a preparação de medicamento para inibição de no-sintase e composições farmacêuticas que os contém | |
DK0954314T3 (da) | Doseringsformer til bedring af mandlig erektionsdefekt | |
MX9605940A (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
BR0113539A (pt) | Processo para a preparação de composições farmacêuticas para uso com formulações de gelatina macia | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
BR0108435A (pt) | Formulação e uso de entecavir de baixa dose | |
BRPI0513598A (pt) | formas de dosagem em comprimidos revestidos de liberação entérica | |
DK1222163T3 (da) | 2'-Substituerede 1,1'-biphenyl-2-carboxamider, fremgangsmåder til fremstilling deraf, deres anvendelse som medikament samt farmaceutiske præparater, som indeholder dem | |
BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
ATE292453T1 (de) | Antivirale arznei | |
AP2003002763A0 (en) | Controlled release formulations for oral administration | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
BRPI0413374A (pt) | composições para liberação de base fraca por um perìodo estendido de tempo | |
PT1144420E (pt) | Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao | |
EA200701091A1 (ru) | Противозачаточный фармацевтический препарат | |
MXPA04002099A (es) | Composiciones medicinales para neuropatia diabetica. | |
BRPI9914031B8 (pt) | partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição. | |
BR9710629A (pt) | Composi-Æo farmac-utica processo para sua prepara-Æo composto para utiliza-Æo como agente terap-utico e utiliza-Æo e utiliza-Æo de um composto | |
BR0311209A (pt) | Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 31/35, A61K 9/20, A61K 9/50, A61K 9/28, A61K 9/48 Ipc: A61K 31/35 (2011.01), A61K 9/20 (2011.01), A61K 9/ |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2315 DE 19-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |